Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals

Giovanni Paolinoa Unit of Dermatology and Cosmetology, IRCCS Ospedale San Raffaele, Milan, ItalyView further author information

Alessandra Narcisib Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, ItalyView further author information

Andrea Carugnoc Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy;d Ph.D. Program in Molecular and Translational Medicine (DIMET), University of Milan-Bicocca, Milan, ItalyView further author information

Piergiorgio Malagolie Dermatology Unit, IRCCS Policlinico San Donato, San Donato, ItalyView further author information

Matteo R. Di Nicolaa Unit of Dermatology and Cosmetology, IRCCS Ospedale San Raffaele, Milan, ItalyView further author information

Antonio Fotia Unit of Dermatology and Cosmetology, IRCCS Ospedale San Raffaele, Milan, ItalyView further author information

Vittoria G. Bianchia Unit of Dermatology and Cosmetology, IRCCS Ospedale San Raffaele, Milan, ItalyView further author information

Andrea Gustavo Locatellic Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, ItalyView further author information

Paolo Senac Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, ItalyView further author information

Antonio Costanzob Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy;f Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information

Santo R. Mercuria Unit of Dermatology and Cosmetology, IRCCS Ospedale San Raffaele, Milan, ItalyView further author information

Mario Valentib Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy;f Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyCorrespondence[email protected]
View further author information

show all

References

Paolino G, Sernicola A, Di Nicola MR, et al. Successful use of dupilumab for the treatment of atopic dermatitis on the genitals, a neglected anatomical site. Clin Exp Dermatol. 2022;47(1):1–4. doi: 10.1111/ced.14894.
Web of Science ®Google Scholar
Yang EJ, Murase JE. Recalcitrant anal and genital pruritus treated with dupilumab. Int J Womens Dermatol. 2018;4(4):223–226. doi: 10.1016/j.ijwd.2018.08.010.
PubMedGoogle Scholar
Woo YR, Han Y, Lee JH, et al. Real‐world prevalence and burden of genital eczema in atopic dermatitis: a multicenter questionnaire‐based study. J Dermatol. 2021;48(5):625–632. doi: 10.1111/1346-8138.15817.
PubMed Web of Science ®Google Scholar
Silverberg JI, Margolis DJ, Boguniewicz M, et al. Distribution of atopic dermatitis lesions in United States adults. J Eur Acad Dermatol Venereol. 2019;33(7):1341–1348. doi: 10.1111/jdv.15574.
PubMed Web of Science ®Google Scholar
Wollenberg A, Blauvelt A, Guttman-Yassky E, ECZTRA 1 and ECZTRA 2 study investigators., et al. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). Br J Dermatol. 2021;184(3):437–449. doi: 10.1111/bjd.19574.
PubMed Web of Science ®Google Scholar

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date